Global Healthcare Distribution Market to Grow at a CAGR of 7.10% During 2026-2035, Aided by the Advancements in Medical Technology

The Asia Pacific region is witnessing significant growth due to the increasing investment in research and development by the Chinese government. In 2022, China invested around USD 166 billion in the pharmaceutical industry, which accounted for around 12% of the global pharmaceutical market.

Additionally, the Chinese government has been working on a five-year strategy (2021–25) for medical technology since April 2021, to have at least six Chinese enterprises rank among the top 50 revenue-generating medical device companies worldwide. The Indian government’s initiatives, such as the Ayushman Bharat Scheme, to improve the healthcare system in rural India, and Assistance to Medical Device Clusters for Common Facilities (AMD-CF) and Japanese companies’ investments in the pharmaceutical and medical device sectors of India further contribute to the healthcare distribution market growth.

Continuous research and development in the healthcare sector strengthens the market growth. Moreover, the launch of innovative solutions by key players such as Cardinal Health (NYSE: CAH) and Tecsys Inc. for optimising the distribution efficiency of the healthcare sector is further aiding the market growth. For instance, in November 2023, Tecsys Inc. announced Elite™ WMS for Healthcare Distribution, a warehouse management system that optimises the efficiency of healthcare distribution and complies with DSCSA regulations.

The solution provides 3PLs and pharmaceutical distributors to locally maintain full inference data on the GS1 system of standards, streamline workflow, ensure the efficiency of critical warehouse operations, and avoid dual-entry workflows.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Market Analysis by Type, End Use, and Region:

• The market, on the basis of type, can be divided into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services.
• Based on end use, the market can be divided into retail pharmacies and hospital pharmacies, among others.
• The major regional markets for healthcare distribution include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Key Findings of the Report:

• According to the United Nations, over the next 30 years, there will likely be a nearly 2 billion increase in the global population, and currently, nearly 10% of the world population is over 65 years old. The rise in the global population and the ageing population creates demand for pharmaceuticals and healthcare products and services.
• In 2020, 79 per cent of fatalities were caused by or included respiratory diseases, diabetes, cancer, cardiovascular disease, and other conditions. Experts estimate the figure might rise to 84 percent by 2030. Digital therapies may aid in the management of disease, such as routine monitoring via linked medical devices.
• The rise of e-commerce and digital medicine platforms such as Netmeds, Medlife, and Apollo Pharmacy 247, among others, has expanded consumer demand for home deliveries of medicines and healthcare distributions. Additionally, improvement in logistics services supports the fast distribution of healthcare products.
• The constant development in research and development and the innovation in specialised medicines positively influence the healthcare distribution market expansion.

Key Offerings of the Report:

• The EMR report gives an overview of the global healthcare distribution market for the periods (2019-2025) and (2026-2035).
• The report also offers the historical (2019-2025) and forecast (2026-2035) markets for the types, end uses, and regions of healthcare distribution.
• The report analyses the market dynamics, covering the key demand and price indicators in the market, along with an assessment of the SWOT and Porter’s Five Forces models.

Top Players:

The major players in the global healthcare distribution market include:

• McKesson Corporation [MCK (NYSE)]
• Cardinal Health [CAH (NYSE)]
• AmerisourceBergen Corporation [ABC (NYSE)]
• Owens & Minor, Inc. [OMI (NYSE)]
• Morris & Dickson Co. L.L.C.
• Priority Healthcare Distribution, Inc.
• FFF Enterprises, Inc.
• Attain Med
• Dakota Drug, Inc.
• Others

The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.

About Us

Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.

EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over a 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.

Contact Us

Expert Market Research
Website: www.expertmarketresearch.com
Email: [email protected]
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790